| Literature DB >> 20092889 |
Megan M Kaneda1, Yo Sasaki, Gregory M Lanza, Jeffrey Milbrandt, Samuel A Wickline.
Abstract
RNA interference (RNAi) is a useful in vitro research tool, but its application as a safe and effective therapeutic agent may benefit from improved understanding of mechanisms of exogenous siRNA delivery, including cell trafficking and sorting patterns. We report the development of a transfection reagent for siRNA delivery which employs a distinctive non-digestive mode of particle-cell membrane interaction through the formation of a hemifusion complex resulting in lipid raft transport of cargo to the cytosol, bypassing the usual endosomal nanoparticle uptake pathway. We further demonstrate markedly enhanced efficacy over conventional transfection agents for suppressing endothelial cell expression of upregulated vascular adhesion molecules. Copyright 2010 Elsevier Ltd. All rights reserved.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20092889 PMCID: PMC2827659 DOI: 10.1016/j.biomaterials.2010.01.006
Source DB: PubMed Journal: Biomaterials ISSN: 0142-9612 Impact factor: 12.479